PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-16-0415
Full Text
Open PDFAbstract
Available in full text
Date
January 23, 2017
Authors
Publisher
American Association for Cancer Research (AACR)